Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Antibe update

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 02, 2020 6:01pm

115 Views

Post# 32022996

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Antibe update

Benedict16th wrote: We have being hoding our breath for seven Yers no more oxigen left with this MNGT

If you call that holding your breath Benny.
Over the years you've been swimming in many different directions Benny.
Might I remind you how positive you were on this company in October of 2019 - when you heard they won the bid for Grupo. You even offered me wine.

I guess wine is off the table then ?

: )

Then you soured during COVID and hyperinflation. Then you decided it was a bad deal. And finally, you are all for removing the only guy who can build ROW. Not one other soul is trying. Only one other company had the opportunity and they changed their mind ... way too tough a job.

---------------

Don't worry Benny, I'll give you something else you'll enjoy. I've been following this for months now and I'm surprised the haters haven't been on it.

I will share now ...